Cholecystokinin plays a key role in driving PDAC by promoting pancreas inflammation [6,7]; cerulein, a cholecystokinin analog, is frequently used to induce experimental pancreatitis and accelerate PDAC development [4]. Here, CCK is linked to pancreatitis.